|
Press Releases |
|
|
|
Tuesday, February 24, 2015 |
|
Additional Exploratory Analysis of Phase II Trial Suggests Anticancer Agent Lenvatinib Extends Overall Survival in Patients with Advanced Non-small Cell Lung Cancer |
Eisai Co., Ltd. announced today the latest results of an additional exploratory analysis of a Phase II clinical trial (Study 703) of its in-house developed anticancer agent lenvatinib mesylate (Lenvima(TM)) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had failed at least two systemic anticancer regimens. more info >> |
|
Thursday, February 19, 2015 |
|
Eisai Receives Approval in Japan for Fine Granule Formulation of Anti-Arrhythmic Agent Tambocor Suitable for Pediatric Patients |
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has received marketing and manufacturing approval in Japan for Tambocor Fine Granules 10%, a new formulation of anti-arrhythmic agent Tambocor (flecainide acetate). more info >> |
|
Wednesday, July 13, 2011 |
|
Eisai Enters into Comprehensive Chinese Marketing Agreement Concerning Breast Cancer and Parkinson's Disease Treatments |
Eisai Co., Ltd. announced today that it has entered into a comprehensive marketing agreement with Orion Corporation (Espoo, Finland) concerning Orion's breast cancer drug Fareston(R) (toremifene citrate) and its Parkinson's disease treatment Eldepryl(R)(selegiline hydrochloride). more info >> |
|
Thursday, November 18, 2010 |
|
Eisai to Provide Medecine to Help WHO Combat Lymphatic Filariasis Epidemic |
Eisai Co., Ltd. announced today that it has signed a statement of intent with the World Health Organization (WHO) to supply free of charge of a primary medicine for the treatment of lymphatic filariasis. more info >> |
|
Tuesday, September 7, 2010 |
|
SymBio and Eisai to Launch Symbenda(R) in Singapore for the Treatment of Low-grade Non-Hodgkin's Lymphoma and Chronic Lymphatic Leukemia |
SymBio Pharmaceuticals Limited and Eisai Co., Ltd. announced today that Eisai's Singapore subsidiary Eisai (Singapore) Pte. Ltd. launched bendamustine hydrochloride ("bendamustine") in Singapore under the brand name Symbenda(R) as a treatment for low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia. more info >> |
|
Wednesday, February 24, 2010 |
|
Eisai Launches REVOVIR(R) in the Philippines for the Treatment of Chronic Hepatitis B |
Eisai Co., Ltd. announced today that the Company's Philippine subsidiary, HI-Eisai Pharmaceutical Inc., launched "REVOVIR(R) 30mg Capsules" (generic name: clevudine) in the Philippines for the treatment of chronic hepatitis B. more info >> |
|
Friday, October 16, 2009 |
|
Eisai Opens Regional Office in Bahrain |
Eisai Co., Ltd. announced today the opening of a regional office in Bahrain. The new office has been established as a branch of its Asian headquarters Eisai Asia Regional Services Pte. Ltd., in Singapore. more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 23, 2024 21:42 JST
|
|
|
First Quarterly Profit, High-Quality Platform Growth, NaaS Technology Accelerates Ecosystem Development
Nov 22, 2024 23:22 HKT/SGT
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results
Nov 22, 2024 19:56 HKT/SGT
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 11:00 HKT/SGT
|
|
|
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
|
|
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT/SGT
|
|
|
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST
|
|
|
GMG Unveils SUPER G(R): A Game-Changing Graphene Solution for the Lithium-Ion Battery Industry
Nov 21, 2024 21:29 HKT/SGT
|
|
|
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Nov 21, 2024 21:20 HKT/SGT
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 20:19 HKT/SGT
|
|
|
SGX-Listed Mooreast Appoints Norwegian Eirik Ellingsen as CEO to Drive Growth in Global Floating Offshore Wind Market
Nov 21, 2024 19:00 HKT/SGT
|
|
|
DesignInspire opens on December 5, with free admission for the public
Nov 21, 2024 17:54 HKT/SGT
|
|
|
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
|
|
|
Yahoo Finance Invest Asia 2024 - Disrupting Finance: Innovations Shaping The Future
Nov 21, 2024 14:14 HKT/SGT
|
|
|
TGL Presented by SoFi Names SYNLawn As Official Synthetic Surface Partner, Providing 31,000 Square Feet of Turf for SoFi Center's Tech-Infused Field of Play
Nov 21, 2024 08:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|